AXL and mucinous ovarian cancer: Although miR-515-3p regulates oxaliplatin sensitivity in mucinous ovarian cancer, in part by targeting AXL [134], there is still a lack of sufficient evidence demonstrating the roles of miRNAs in regulating the GAS6/AXL pathway.